Sotac Pharmaceuticals Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sotac Pharmaceuticals Limited has announced a board meeting for the review of the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025, confirming no requests for dematerialization or rematerialization of shares during this period. This update suggests stability in shareholder engagement and confidence in the current structure of share ownership. The absence of demat activity could indicate a steady investor sentiment, reflecting a neutral impact on share liquidity. Overall, this maintains a positive outlook for operational consistency.